Search hospitals > Alabama > Anniston
Pinnacle Research Group, LLC
Claim this profileAnniston, Alabama 36207
Global Leader in Arthritis
Global Leader in Rheumatoid Arthritis
Conducts research for Systemic Lupus Erythematosus
Conducts research for Lupus
Conducts research for Type 2 Diabetes
132 reported clinical trials
3 medical researchers
Summary
Pinnacle Research Group, LLC is a medical facility located in Anniston, Alabama. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus, Type 2 Diabetes and other specialties. Pinnacle Research Group, LLC is involved with conducting 132 clinical trials across 113 conditions. There are 3 research doctors associated with this hospital, such as Vishala Chindalore, MD, Almena L Free, and Stacy J Haynes.Area of expertise
1Arthritis
Global LeaderACPA positive
RF positive
Stage II
2Rheumatoid Arthritis
Global LeaderACPA positive
RF positive
Stage II
Top PIs
Vishala Chindalore, MDPinnacle Research Group, LLC2 years of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
7 reported clinical trials
10 drugs studied
Almena L FreeGSK Investigational Site2 years of reported clinical research
Studies Flu
Studies Cardiovascular Disease
4 reported clinical trials
7 drugs studied
Stacy J HaynesPinnacle Research Group, LLC4 years of reported clinical research
Studies Atopic Dermatitis
Studies Eczema
1 reported clinical trial
1 drug studied
Clinical Trials running at Pinnacle Research Group, LLC
Systemic Lupus Erythematosus
Lupus
Rheumatoid Arthritis
Arthritis
Cardiovascular Disease
Chronic Obstructive Pulmonary Disease
Cutaneous Lupus Erythematosus
Obstructive Sleep Apnea
Autoimmune Diseases
Sjogren's Syndrome
Ianalumab
for Autoimmune Diseases
The purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector (AI) versus two injections of 150 mg/1 mL pre-filled syringe (PFS), and to evaluate the safety and tolerability of ianalumab following the s.c. administration of both devices in participants with rheumatoid arthritis (RA), Sjögren's disease (SjD), or systemic lupus erythematosus (SLE). A second optional cohort may be included with the objective of demonstrating the comparability of pharmacokinetics of ianalumab between 1 x 2 mL Pre-filled Syringe (PFS) and 2 x 1 mL PFS.
Recruiting1 award Phase 22 criteria
Ianalumab
for Lupus
The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).
Recruiting1 award Phase 31 criteria
Ianalumab
for Lupus
This trial will test if ianalumab, an injection given regularly, is safe and effective for people with active systemic lupus erythematosus (SLE). The medication aims to calm down their overactive immune system to reduce inflammation and damage.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Pinnacle Research Group, LLC?
Pinnacle Research Group, LLC is a medical facility located in Anniston, Alabama. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus, Type 2 Diabetes and other specialties. Pinnacle Research Group, LLC is involved with conducting 132 clinical trials across 113 conditions. There are 3 research doctors associated with this hospital, such as Vishala Chindalore, MD, Almena L Free, and Stacy J Haynes.